RecruitingNCT05219851
The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors
The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors.in Real-world Clinical Practice: a Multicenter, Prospective, Open, Non-interventional Study
Sponsor
Hubei Cancer Hospital
Enrollment
250 participants
Start Date
Jun 1, 2022
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this non-interventional study is to collect data on the risk factors for acute radiation pneumonitis in patients with prior receipt of immune checkpoint inhibitors.
Eligibility
Inclusion Criteria2
- Pathologically or cytologically confirmed malignant tumor
- Cancer patients with previously received ICIs underwent thoracic intensity-modulated radiotherapy
Exclusion Criteria2
- Cancer patients did not receive immunotherapy before thoracic intensity-modulated radiotherapy
- Non-thoracic radiotherapy patients
Interventions
RADIATIONCancer patients underwent thoracic intensity-modulated radiotherapy
Cancer patients underwent thoracic intensity-modulated radiotherapy, previously received ICIs
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05219851